Brief: Somalogic Sees FY Revenue About $105 Million To $110 Million
Feb 4 (Reuters) - Somalogic Inc SLGC.O :
* SEES FY REVENUE ABOUT $105 MILLION TO $110 MILLION
* PROJECTS 2022 REVENUE OF APPROXIMATELY $105 MILLION TO
$110
MILLION
* FY2022 REVENUE VIEW $103.5 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX6lF37r
Further company coverage: SLGC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Somalogic
See all newsBrief: Somalogic Stockholders Vote To Approve Standard Biotools Transaction At Special Meeting
Brief: Madryn Asset Management Demands Somalogic’S Board Address Repeated, Unprecedented Adjournments Of Tainted Special Meeting
Brief: Madryn Asset Management Says It Urges All Somalogic Shareholders To Oppose Transaction With Standard Biotools
Brief: Madryn Asset Management Urges Shareholders To Vote “Against” The Proposed Merger And Allow Somalogic To Pursue Value-Enhancing Alternatives
Brief: Somalogic Board Reiterates Value-Maximizing Transaction With Standard Biotools Is In Best Interests Of All Stockholders